1
|
Bitencourt PER, Bona KSD, Cargnelutti LO, Bonfanti G, Pigatto A, Boligon A, Athayde ML, Pierezan F, Zanette RA, Moretto MB. Syzygium cumini seed extract ameliorates adenosine deaminase activity and biochemical parameters but does not alter insulin sensitivity and pancreas architecture in a short-term model of diabetes. J Complement Integr Med 2016; 12:187-93. [PMID: 25955284 DOI: 10.1515/jcim-2015-0008] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/10/2015] [Accepted: 04/21/2015] [Indexed: 01/12/2023]
Abstract
BACKGROUND The effects of the aqueous seed extract of Syzygium cumini (ASc) in a short-term model of diabetes in rats are little explored. The present study was designed to evaluate the effect of the ASc on adenosine deaminase (ADA) activity and on biochemical and histopathological parameters in diabetic rats. METHODS ASc (100 mg/kg) was administered for 21 days in control and streptozotocin (STZ)-induced (60 mg/kg) diabetic rats. ADA activity, lipoperoxidation (cerebral cortex, kidney, liver and pancreas) and biochemical (serum) and histopathological (pancreas) parameters were evaluated. RESULTS The main findings in this short-term model of Diabetes mellitus (DM) were that the ASc (i) significantly reverted the increase of ADA activity in serum and kidney; (ii) ameliorated the lipoperoxidation in the cerebral cortex and pancreas of the diabetic group; (iii) demonstrated hypolipidemic and hypoglycemic properties and recovered the liver glycogen; and iv) prevented the HOMA-IR index increase in the diabetic group. Therefore, the ASc can be a positive factor for increasing the availability of substrates with significant protective actions, such as adenosine. Moreover, by maintaining glycogen and HOMA-IR levels, the extract could modulate the hyperglycemic state through the direct peripheral glucose uptake. CONCLUSIONS Our data revealed that the short-term treatment with ASc has an important protective role under pathophysiological conditions caused by the early stage of DM. These results enhance our understanding of the effect of the ASc on the purinergic system in DM.
Collapse
|
2
|
Bonfanti G, Bitencourt PER, Bona KSD, Peroza LR, Cargnelutti LO, Borges RM, Pigatto AGS, Fachinetto R, Boligon AA, Athayde ML, Gonçalves TDL, Moretto MB. Safety assessment and behavioral effects of Solanum guaraniticum leaf extract in rats. BRAZ J PHARM SCI 2016. [DOI: 10.1590/s1984-82502016000100006] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023] Open
Abstract
ABSTRACT Solanum guaraniticum is a medicinal plant traditionally used to treat gastric and liver diseases. However, there is no documented evidence corroborating its safety. The present study evaluated the potential toxicity of S. guaraniticum leaf extract after acute administration in rats. Single doses of the extract (1.250, 2.500, and 5.000 mg/kg) were administered by gavage, and the rats were then monitored for 48 h and/or 14 days. Mortality, acute signs of toxicity, and general activity in the open field test were assessed as well as hematological and biochemical parameters, enzymatic activity (δ-aminolevulinate dehydratase and acetylcholinesterase), and oxidative stress parameters (lipid peroxidation level, non-protein thiol content, tissue catalase activity, and serum ferrous reducing power). Phytochemical analysis was also performed by HPLC. The results showed that extract administration produced no deaths (LD50 > 5,000 mg/kg), and no significant adverse effects regarding food consumption, body weight gain, gross pathology, or other parameters. However, the open field tests showed a decrease in spontaneous activity (crossing and rearing) mainly at 48 h after treatment. The results suggest that S. guaraniticum extract is not acutely toxic, but causes alterations in central nervous system activity.
Collapse
|
3
|
Bitencourt PER, Bellé LP, Bonfanti G, Cargnelutti LO, Bona KSD, Silva PS, Abdalla FH, Zanette RA, Guerra RB, Funchal C, Moretto MB. Differential effects of organic and inorganic selenium compounds on adenosine deaminase activity and scavenger capacity in cerebral cortex slices of young rats. Hum Exp Toxicol 2013; 32:942-9. [DOI: 10.1177/0960327113479045] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Selenium (Se) has anti-inflammatory and antioxidant properties and is necessary for the development and normal function of the central nervous system. This study was aimed to compare the in vitro effects of 3-methyl-1-phenyl-2-(phenylseleno)oct-2-en-1-one (C21H2HOSe; organoselenium) and sodium selenate (inorganic Se) on adenosine deaminase (ADA) activity, cell viability, lipid peroxidation, scavenger of nitric oxide (NO) and nonprotein thiols (NP-SH) content in the cerebral cortex slices of the young rats. A decrease in ADA activity was observed when the slices were exposed to organoselenium at the concentrations of 1, 10 and 30 µM. The same compound showed higher scavenger capacity of NO than the inorganic compound. Inorganic Se was able to protect against sodium nitroprusside-induced oxidative damage and increased the NP-SH content. Both the compounds displayed distinctive antioxidant capacities and were not cytotoxic for the cerebral cortex slices in the conditions tested. These findings are likely to be related to immunomodulatory and antioxidant properties of this compound.
Collapse
Affiliation(s)
- PER Bitencourt
- Postgraduate Program in Pharmaceutical Sciences, Health Science Center, Federal University of Santa Maria, Santa Maria, RS, Brazil
| | - LP Bellé
- Postgraduate Program in Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil
| | - G Bonfanti
- Postgraduate Program in Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil
| | - LO Cargnelutti
- Postgraduate Program in Pharmaceutical Sciences, Health Science Center, Federal University of Santa Maria, Santa Maria, RS, Brazil
| | - KS de Bona
- Postgraduate Program in Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil
| | - PS Silva
- Postgraduate Program in Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil
| | - FH Abdalla
- Postgraduate Program in Pharmaceutical Sciences, Health Science Center, Federal University of Santa Maria, Santa Maria, RS, Brazil
| | - RA Zanette
- Postgraduate Program in Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil
| | - RB Guerra
- Federal Institute of Education, Science and Technology of Rio Grande do Sul, Sertão, RS, Brazil
| | - C Funchal
- Postgraduate Program in Biosciences and Rehabilitation, Methodist University Center, IPA, Porto Alegre, RS, Brazil
| | - MB Moretto
- Postgraduate Program in Pharmaceutical Sciences, Health Science Center, Federal University of Santa Maria, Santa Maria, RS, Brazil
- Postgraduate Program in Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil
| |
Collapse
|